Global Plaque Modification Devices Market was valued at USD 1.21 billion in 2021

The global plaque modification devices market was valued at USD 1.21 billion in 2021, growing at a CAGR of 8.09% during the forecast period from 2022 to 2027, in order to reach USD 1.93 billion by 2027. Plaques are fatty waxy substance that deposits in the walls of the artery. These depositions can narrow the artery and reduce the blood flow. Sometimes, plaques can also rupture and create a blood clot at the rupture site. The increase in demand for plaque modification devices is predominantly attributed to the continuous expansion of the old age population across the globe, rising sedentary lifestyle and associated disorders, increase in obesity among the population, worldwide, among others which are the major risk factors for developing arterial plaques. In addition, approval and launch of plaque modification devices, strategic business activities among key players for market expansion in plaque modification products, among others are some of the factors expected to drive the global plaque modification devices market.

Plaque Modification Devices
Plaque in the arteries is a deposition of a fatty, waxy substance that can narrow the artery and reduce blood flow. Plaque modification devices are intended for the removal of plaque and other debris from the arteries, which carry the blood to the heart and brain.

Download Sample Report- https://www.delveinsight.com/sample-request/plaque-modification-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Regions covered in the report
• Global

Recent Developmental Activities in the Plaque Modification Devices Market:
• In September 2021, Abbott acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots.
• In February 2021, Shockwave Medical, Inc. a medical device company focused on the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, received Pre-Market Approval from the US FDA for the company's sonic pressure wave device to treat severely calcified coronary artery disease.
• In January 2021, Cardiovascular Systems Inc. received CE Mark for Diamondback 360® Coronary Orbital Atherectomy System.
• In September 2020, AngioDynamics Inc. commercially launched the Auryon Atherectomy System, a newly-developed innovative technology for the treatment of Peripheral Artery Disease (PAD), including Critical Limb Ischemia (CLI) and In-Stent Restenosis (ISR).

Key Takeaways from the Plaque Modification Devices Market Report Study
• Market size analysis for current Plaque Modification Devices market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Plaque Modification Devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the Global Plaque Modification Devices Market.
• Various opportunities available for the other competitor in the Plaque Modification Devices Market space.
• What are the top-performing segments in 2021? How these segments will perform in 2027.
• Which are the top-performing regions and countries in the current market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Plaque Modification Devices market growth in the coming future?

Click here for more information about the report offering- https://www.delveinsight.com/report-store/plaque-modification-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

COVID19 Impact on the Plaque Modification Devices Market
With the outbreak of the COVID-19 pandemic, the demand for plaque modification devices in the market decreased. This was because many routine procedures and outpatient visits were temporarily suspended and global healthcare facilities were temporarily focused on managing the burden of COVID-19 patients during the initial lockdown period. However, owing to the approval and administration of numerous COVID-19 vaccines across the globe in the second half of 2020, there was a significant improvement in the resumption of activities across various domains, including healthcare services, thereby paving the way for a sound period of recovery for the plaque modification devices market. However, the strict regulatory approval process for the plaque modification devices and complications associated with devices and surgical procedures are likely to impede the plaque modification devices market growth.

Plaque Modification Devices Market Segmentation
• Plaque Modification Devices Market By Product Type (Atherectomy Devices, Thrombectomy Devices, Chronic Total Occlusion (CTO) Devices, Embolic Protection Devices, Others)
• Plaque Modification Devices Market By Application (Coronary Artery Diseases, Peripheral Artery Diseases, Neurovascular Diseases)
• Plaque Modification Devices Market By End-User (Hospitals, Ambulatory Surgical Centres, Others)
• Plaque Modification Devices Market By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Plaque Modification Devices Product Type Segment
The atherectomy devices are anticipated to hold a significant share during the forecasted period. This is owing to the availability of different atherectomy devices such as directional atherectomy systems, orbital atherectomy systems, rotational atherectomy systems, and others in the market. In addition, advantages such as better clinical outcomes as compared to primary stenting during angioplasty and cost-effectiveness of the procedure will further raise their demand.
Plaque Modification Devices Market Companies
Some of the key market players operating in the Plaque Modification Devices market include Boston Scientific Corporation, Medtronic, Abbott, Shockwave Medical, Inc., Cardiovascular Systems, Inc., AngioDynamics, Inc., Avinger, REX MEDICAL, Ra Medical Systems, Koninklijke Philips N.V., Becton, Dickinson and Company, Penumbra, Inc., Stryker, Microvention, Inc., Johnson & Johnson, ARGON MEDICAL., Inari Medical, Nitiloop, Soundbite Medical Solutions, Rontis Corporation, among others.

Request Sample Report- https://www.delveinsight.com/sample-request/plaque-modification-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Plaque Modification Devices Market Report Introduction
2. Plaque Modification Devices Market Executive summary
3. Regulatory and Patent Analysis
4. Plaque Modification Devices Market Key factors analysis
5. Plaque Modification Devices Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Plaque Modification Devices Market
7. Plaque Modification Devices Market layout
8. Plaque Modification Devices Global Company Share Analysis - Key 3-5 Companies
9. Plaque Modification Devices Company and Product Profiles
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us

Do you have any query related to the report? If yes, click here- https://www.delveinsight.com/report-store/plaque-modification-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Contact Us
Yash
info@delveinsight.com

About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.